Financials

  • Market Capitalization 3 B
  • Employee 198
  • Founded 1983
  • CEO N/A
  • Website www.celldex.com
  • Headquarter Delaware, United States
  • FIGI BBG000FW8LZ9
  • Industry Biotecnología
Ingresos totales
Beneficio neto
Beneficio básico por acción
Deuda total
Flujo de caja libre
Efectivo y equivalentes
Ratio precio/beneficio
-7.43
Relación precio/flujo de caja
2.89

Related tickers

#NombrePrecio24h %7d %1M %1A %CapitalizaciónÚltimos 7 días
1673
ELVN
Enliven Therapeutics, Inc. - Common Stock
51.75 USD+0.04%+2.31%+21.74%+150.48%3.15 B USD
1686
VERA
Vera Therapeutics, Inc. - Class A Common Stock
42.20 USD-2.16%-1.49%+22.35%+41.90%3.03 B USD
1758
IRON
Disc Medicine, Inc. - Common Stock
74.92 USD-0.12%-5.20%+8.49%+29.19%2.86 B USD
1794
KOD
Kodiak Sciences Inc - Common Stock
41.50 USD-4.07%+2.72%+21.74%+753.91%2.60 B USD

Noticias